Revvity

Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure.

Revvity is pushing the limits of what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With a robust global network and localized agility, we serve a diverse range of organizations from pharmaceutical and biotech, to clinical labs, academia, and governments.

Together with our customers and partners, we are united in impact, embracing the impossible to improve lives everywhere.

Contact Information:

Revvity
940 Winter St.
Waltham,
Massachusetts 02451,
United States
Phone: 1-781-663-6900

Company website

Content by Revvity:

Outside the Lab Profession

Power Profiles: Madhuri Hegde

08/01/2023 | Sponsored by Revvity

Celebrating a powerful presence in the industry

Inside the Lab Technology and innovation

Better Science, Better Health – for All

07/25/2023 | Sponsored by Revvity | 3 min read

An interview with Yves Dubaquie

Inside the Lab Technology and innovation

The Next Generation of Laboratory Automation

09/13/2022 | Sponsored by Revvity | 3 min read

PerkinElmer’s BioQule™ NGS system represents the next step forward in entry-level automation

Inside the Lab Omics

Drifting From the Norm

03/11/2022 | Sponsored by Revvity

PerkinElmer are demonstrating the advantages of bead-based normalization for next-generation sequencing

Inside the Lab Technology and innovation

HIVE™: The Bees’ Knees of Single-Cell Technology

12/01/2021 | Sponsored by Revvity

The portable, handheld device delivering innovation to the single-cell genomics space

Evaluation of cell-free fetal DNA to determine fetal RhD status

09/07/2023 | Contributed by Revvity

Explore the compatibility of the FetoGnost® Kit RHD with extracted cffDNA obtained with the chemagic™ 360 instrument to determine fetal RhD status

Preventing Bias in scRNAseq Performed on Solid Tumors

04/06/2023 | Contributed by Revvity

Enabling Efficient, Cost-effective Sequencing of the Human Whole Exome

03/01/2023 | Contributed by Revvity

Diagnostics Genetics and epigenetics

New easy-to-use automated system for NGS library prep

07/05/2022 | Contributed by Revvity

Construct 8 libraries with only 15 minutes of hands-on-time with the BioQule™ NGS System!

HIVE scRNAseq Solution: A Case Study Demonstrating Sample Stability & Fragile Cell Recovery

01/04/2022 | Contributed by Revvity

The HIVE™ scRNAseq Solution integrates sample storage and single cell profiling into a single workflow

NEXTFLEX Variant-Seq™ SARS-CoV-2 Kit

07/12/2021 | Contributed by Revvity

The NEXTFLEX Variant-Seq™ SARS-CoV-2 Kit identifies all mutations in a SARS-CoV-2 sample using Next Generation Sequencing (NGS).

Simplified SARS-CoV-2 Variant Detection

07/12/2021 | Contributed by Revvity

The NEXTFLEX^® Variant-Seq™ SARS-CoV-2 kit simplifies the tracking and identification of mutations associated with SARS-CoV-2 variants

Quantify Cellular Interactions in the Tumor Microenvironment and Develop Better Biomarkers

04/23/2018 | Contributed by Revvity

Visualize, quantify, and phenotype in situ in FFPE tissue sections and TMAs

03/05/2018 | Contributed by Revvity

Vectra® Polaris™ Automated Quantitative Pathology Imaging System

03/06/2017 | Contributed by Revvity

Webinars on Demand

Diagnostics Genetics and epigenetics

Hunt for pathogenic variants in Type 2 diabetes through NGS

06/21/2022 | Sponsored by Revvity

In this webinar, Dr. Amelie Bonafond will present the current sequencing (via whole-exome sequencing) of all the patients with common T2D visiting the department of Diabetology of Liège Hospital (n > 4000 participants).